Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck’s Welireg Gets Orphan Pricing Ahead Of Broader RCC Indications
Drug From $1.1bn Peloton Buy Boosts Renal Cancer Franchise
Aug 16 2021
•
By
Mandy Jackson
Merck priced Welireg at $26,400 per month, before discounts and rebates • Source: Alamy
More from New Products
More from Scrip